0001209191-21-023069.txt : 20210325
0001209191-21-023069.hdr.sgml : 20210325
20210325173952
ACCESSION NUMBER: 0001209191-21-023069
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210323
FILED AS OF DATE: 20210325
DATE AS OF CHANGE: 20210325
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Klein Lawrence Otto
CENTRAL INDEX KEY: 0001762583
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37923
FILM NUMBER: 21773711
MAIL ADDRESS:
STREET 1: C/O CRISPR THERAPEUTICS AG
STREET 2: 610 MAIN STREET 7TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CRISPR Therapeutics AG
CENTRAL INDEX KEY: 0001674416
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 473173478
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
BUSINESS PHONE: 6173154600
MAIL ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-23
0
0001674416
CRISPR Therapeutics AG
CRSP
0001762583
Klein Lawrence Otto
C/O CRISPR THERAPEUTICS, INC.
610 MAIN STREET
CAMBRIDGE
MA
02139
0
1
0
0
CBO & COO
Common Shares
2021-03-23
4
M
0
12000
44.67
A
25050
D
Common Shares
2021-03-23
4
M
0
22000
51.49
A
47050
D
Common Shares
2021-03-23
4
M
0
10000
29.87
A
57050
D
Common Shares
2021-03-23
4
M
0
20000
40.87
A
77050
D
Common Shares
2021-03-23
4
M
0
12000
14.43
A
89050
D
Common Shares
2021-03-23
4
M
0
12000
17.66
A
101050
D
Common Shares
2021-03-23
4
S
0
88000
128.20
D
13050
D
Common Shares
2021-03-23
4
S
0
12000
126.97
D
1050
D
Stock Option (Right to Buy)
14.43
2021-03-23
4
M
0
12000
0.00
D
2027-06-14
Common Shares
12000
2666
D
Stock Option (Right to Buy)
17.66
2021-03-23
4
M
0
12000
0.00
D
2027-11-14
Common Shares
12000
3000
D
Stock Option (Right to Buy)
51.49
2021-03-23
4
M
0
22000
0.00
D
2028-03-06
Common Shares
22000
38000
D
Stock Option (Right to Buy)
29.87
2021-03-23
4
M
0
10000
0.00
D
2029-01-01
Common Shares
10000
10000
D
Stock Option (Right to Buy)
40.87
2021-03-23
4
M
0
20000
0.00
D
2029-03-05
Common Shares
20000
25000
D
Stock Option (Right to Buy)
44.67
2021-03-23
4
M
0
12000
0.00
D
2030-03-10
Common Shares
12000
43000
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.78 to $132.255, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.80 to $130.015, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
100% of the shares shall vest in 48 equal monthly installments on the fifteenth day of each month, with the first vesting event on July 15, 2017.
100% of the shares shall vest in 48 equal monthly installments on the fifteenth day of each month, with the first vesting event on December 15, 2017.
100% of the shares shall vest in 48 equal monthly installments on the seventh day of each month, with the first vesting event on April 7, 2018.
25% of the option shall vest on January 2, 2020, and the remaining 75% of the shares shall vest in 36 equal monthly installments on the final day of each month.
This option was granted on March 5, 2019 with respect to 45,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 5, 2019.
This option was granted on March 10, 2020 with respect to 55,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 10, 2020.
/s/ Michael Esposito, attorney-in-fact
2021-03-25